{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:45:39Z","timestamp":1786977939763,"version":"build-2736575974"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["11\u2010108395"],"award-info":[{"award-number":["11\u2010108395"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2019,3,15]]},"abstract":"<jats:p>Laboratory studies suggest that inhibition of the cyclooxygenase (COX)\u20102 enzymes inhibits breast cancer development. We aimed to evaluate whether postdiagnosis use of COX\u20102 selective or other nonaspirin nonsteroidal anti\u2010inflammatory drugs (NSAIDs) reduce the risk of contralateral breast cancer (CBC) among Danish breast cancer patients. From the clinical database of the Danish Breast Cancer Group, we identified 52,723 women diagnosed with breast cancer between 1996 and 2012. Data on nonaspirin NSAID use, CBC and potential confounding variables were obtained from nationwide registries. We defined postdiagnosis use (two or more prescriptions) as a time\u2010varying covariate with a one\u2010year lag. Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for CBC associated with nonaspirin NSAID use. During a median follow\u2010up of 4.8 years (interquartile range: 2.3\u20139 years), 1,444 patients were diagnosed with CBC. Overall, postdiagnosis use of nonaspirin NSAID was associated with an adjusted HR for CBC of 0.98 (95% CI: 0.87\u20131.11). The HRs did not vary substantially with duration or intensity of nonaspirin NSAID use. Moreover, similar associations were found for COX\u20102 selective (HR: 1.02; 95% CI: 0.85\u20131.23) and nonselective (HR: 0.96; 95% CI: 0.82\u20131.13) nonaspirin NSAIDs. In conclusion, our nationwide cohort study of breast cancer patients does not suggest a reduced risk of CBC with nonaspirin NSAID use regardless of the COX\u20102 selectivity.<\/jats:p>","DOI":"10.1002\/ijc.31949","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T07:58:27Z","timestamp":1540540707000},"page":"1243-1250","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nonaspirin NSAIDs and contralateral breast cancer risk"],"prefix":"10.1002","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4949-8191","authenticated-orcid":false,"given":"Annet","family":"Bens","sequence":"first","affiliation":[{"name":"Unit of Virus, Lifestyle and Genes Danish Cancer Society Research Center  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Cronin\u2010Fenton","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dehlendorff","sequence":"additional","affiliation":[{"name":"Unit of Statistics and Pharmacoepidemiology Danish Cancer Society Research Center  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj\u2010Britt","family":"Jensen","sequence":"additional","affiliation":[{"name":"Danish Breast Cancer Group, Rigshospitalet  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent","family":"Ejlertsen","sequence":"additional","affiliation":[{"name":"Danish Breast Cancer Group, Rigshospitalet  Copenhagen Denmark"},{"name":"Department of Oncology, Rigshospitalet  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kroman","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery Herlev University Hospital  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Aarhus University  Aarhus Denmark"},{"name":"Unit of Statistics and Pharmacoepidemiology Danish Cancer Society Research Center  Copenhagen Denmark"},{"name":"Department of Public Health University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Mellemkj\u00e6r","sequence":"additional","affiliation":[{"name":"Unit of Virus, Lifestyle and Genes Danish Cancer Society Research Center  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1678"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1524"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010787200"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000452315"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3267-9"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.4.252"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S59156"},{"key":"e_1_2_6_9_1","first-page":"855","article-title":"Epidemiology of contralateral breast cancer","volume":"8","author":"Chen Y","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70030-4"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.09.015"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S23826"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt211"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu202"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","unstructured":"R Foundation for Statistical Computing. R: A language and environment for statistical computing. Available at:https:\/\/www.R-project.org\/. Accessed 1 Sep 2017.","DOI":"10.1201\/9780203758212-1"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8"},{"key":"e_1_2_6_18_1","unstructured":"AllignolA.kmi: Kaplan\u2010Meier Multiple Imputation for the Analysis of Cumulative Incidence Functions in the Competing Risks Setting. R package version 0.5.2. Available at:https:\/\/CRAN.R-project.org\/package=kmi. Accessed 1 Sep 2017."},{"key":"e_1_2_6_19_1","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris RE","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-27"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2010.07.004"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2692-4"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-5-159"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2482"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1979-1"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0241"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-626"},{"key":"e_1_2_6_28_1","unstructured":"Danish Medicines Agency. Over\u2010the\u2010counter medicines. Available at:https:\/\/laegemiddelstyrelsen.dk\/en\/pharmacies\/over-the-counter-medicines\/. Accessed 20 July 2018."},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/453012"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.31949","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.31949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:49:11Z","timestamp":1694720951000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.31949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,3,15]]}},"alternative-id":["10.1002\/ijc.31949"],"URL":"https:\/\/doi.org\/10.1002\/ijc.31949","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"assertion":[{"value":"2018-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}